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ABSTRACT  
Breast cancer has very complex morphological and molecular 
characteristic. Estrogen receptor is one of biomarker in breast 
cancer progression, more than 60% breast cancer overexpress 
estrogen receptor α (ERα). Xanthone in Garcinia mangostana was 
investigated whether to have anticancer activity on colorectal, 
prostate, lung, blood and breast cancer. This research was focused 
on molecular mechanism of anticancer activity of mangosteen 
pericarp extract (MPE) on ER-α. This study used MCF-7 cells as a 
model of ER-α overexpressed breast cancer cells. Cytotoxic study 
towards MCF-7 cells was designed by using MTT test, further 
apoptotic induction assay was determined by double staining 
method using acridine orange and ethidium bromide. Extract 
molecular mechanism against breast cancer was assayed by 
immunocytochemistry. The MTT data was analyze using probit 
analysis to get IC50 then apoptosis and immunocytochemistry data 
were analysis qualitative analysis. MPE had strong cytotoxic activity 
on MCF-7 cells with IC50 of 45μg/mL and morphological changes 
passed through apoptosis induction. The expression of ER-α in MPE 
treated cells was same as untreated cells. MPE did  not suppress  
ER-α in both nucleus and cytoplasm. Anticancer activity of MPE 
misht be mediated by other gene involved in ER-α signaling 
pathway in breast cancer cells. 
 




The  most commonly diagnosed types of 
cancer among women in 2012 was breast 
cancer and breast cancer is expected to account 
for 29% (226,870) of all new cancer cases 
among women (Siegel et al., 2012). In 2005, 
186.467 women suffered from breast cancer 
and 41.116 of them passed away because of 
these disease (CDC, 2009). Breast cancer was 
the major caused death cancer after cervical 
cancer in Indonesia (Idamardi, 2007).  
Breast cancer has very complex 
morphological and molecular characteristic. 
One important marker of breast cancer for 
prognosis is estrogen reseptor (Giacinti et al., 
2006). Approximately 60% of breast cancer 
over expressed estrogen receptor-α (ER-α) 
(Hanstein et al., 2004). The development of 
molecular targeted drug has great advanced to 
cancer therapy. ER-α is a molecular target to 
stop the progression of breast cancer.  
 Mangosteen (Garcinia mangostana Linn) 
pericarp contains various phytochemicals, 
primary xanthones. Xanthone isolated from 
mangosteen pericarps were: α-mangostin, β-
mangostin, γ-mangostin, mangostinone and 2-
isoprenyl-1,7 dihydroxy-3-methoxy xanthone 
inhibited human leukimia HL60 cell line. 
Among them, α-mangostin suppresed 
proliferation and induced apotosis of HL60 
cells at 10μM (Matsumoto et al., 2003). 
Xanthone extract (81% α-mangostin and γ 
mangostin) suppressed HT116 colon cancer 
cell (Aisha et al., 2012; Nabandith et al., 2004; 
Nakagawa et al., 2007). Xanthone: α-mangostin, 
β-mangostin, γ-mangostin had anticancer 
activity on DLD-1 (Akao et al., 2008). Alpha 
mangostin had antiproliferative activity against 
SKBR3 human breast adenocarcinoma cell line 
(Moongkarndi et al., 2004) and MDA-MB231 
(Kurose et al., 2012). This compound were also  
proof  to reduce lymph node  
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metastasis in xenograft model in Balb/c mice 
(Shibata et al., 2011). Garcinia mangostana Linn 
pericarp extract has potential property to be 
chemopreventive agent against breast cancer. 
This study investigated Garcinia 
mangostana pericarp extract (MPE) activity 
against breast cancer. Furthermore, it focused 
on ERα as molecular target to suppress 
proliferation of MCF-7 cell, in vivo model of 
ER-α over expressed breast cancer cell.  
 
MATERIAL AND METHODS 
MPE was purchased from PT. 
Borobudur had 28.10% α-mangosteen. Fructus 
cortex of Garcinia mangostana Linn was extracted 
use 70% ethanol with ratio botanical extract 
10:1 and used maltodextrine as its excipient. 
MCF-7 breast cancer cell line was cultured in 
Parasitology laboratory, Faculty of Medicine, 
Gadjah Mada University. Apoptosis staining 
using ethidium bromide and acridine orange 
from SIGMA. This research used US BIO 
estrogen receptor α primary antibody.   
 
MTT Cytotoxic Assay 
MCF-7 cells breast cancer cell line were 
subcultured until confluent. Approximately 
5x103 cells were seeded into 96-well microplate 
and incubated at 37°C and 5% CO2 for 24h. 
Medium was  fride treatment control, were 
prepared from Tamofen® tablet. MPE and 
tamoxifen were dissolved in DMSO as stock 
solutions. Various concentration of MPE and 
tamoxifen in medium were added into 96-well 
plate 100μL each and incubated in the same as 
previous condition for 24h. Each concentration 
was assayed in triplicates (n=3). The medium 
culture was removed and rinsed by PBS 10%,  
one hundreds micro Liter I 100μL contain 
5mg/mL MTT was added into each well and 
incubated feather for 4h. Event, medium 
containing MTT was removed and 100μL SDS 
was added each well to dissolve the optical 
density of the resulting solution. The 96-well 
microplate was incubated for 24h and avoid 
from light contact. Formazan crystals were 




MCF-7 were seeded 5x104/100μL into 
coverslip in 24-well plate, then adapted in 37°C 
and 5% CO2 for 24h. Further, the medium was 
removed and rinsed by PBS.  Seventeen and 
34µg/mL of MPE in Dulbecco’s Modified 
Eayle’s Medium were added into the well plate 
and incubated for 24h. These concentrations 
were determined fariure calculation IC50, as 
estimated concentration closed to IC50. The 
medium was removed from MCF-7 cells and 
rinsed by PBS. The coverslip was removed 
from well plate and transferred to object glass, 
and acridine orange-ethidium bromide (AE) 
was dropped at the coverslip. This slide was 
soon observed under flouresence microscope. 
 
Immunocytostaining of ER-α  
MCF-7 cells in DMEM was seeded 
105/100μL on 6-well plate and incubated under 
5%  CO2  for 24h. MPE in concentration of 17 
and 34µg/mlL were applied on cells and 
incubated for 24 hours. After incubation, cells 
was collected and washed in PBS. They were 
resuspended in DMEM and placed in object 
glass, fixated for 5min, incubated in H2O2 for 
10-15min and then washed again using PBS. 
Monoclonal antibody anti ER-α was and 
incubated at least for an hour and washed three 
time using PBS. Secondary antibody of 
biotinylated goat anti-polyvalent was added and 
incubated at room temperature for 10min and 
washed four times in PBS. DAB as chromogen 
the mistune was dropped and incubated for and 
3-8min, washed using aquadest. Finally, 
hematoxylin solution was added and incubated 
for 3-4 minutes. This slides were dried and 
observed under light microscope. Expression 
of ER-α was showed by brown cell colour. 
 
Analysis 
The cytotoxic data of MPE and 
tamoxifen were analyzed by excel. IC50 was 
then calculated using probit analysis (Finney 
and Stevens, Any new references?   
 
RESULT  AND DISCUSSION 
This study investigated another cytotoxic 
properties of Garcinia mangostana pericarp 
against breast cancer cell line. MCF-7 was used 
as  in vivo model of over expressed ER-α cells. 
MPE and tamoxifen were dissolved into excess 
DMSO as inert solvent in cell culture. Cavalli et 
al. (2011) and Licciardi et al. (2010) showed      
that   DMSO  2µL in volume (2% v/v) have no  
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cytotoxic activity against MCF-7 cells. This 
research used 0.02% v/v DMSO for MPE and 
oxifen. MTT was absorbed into living cells and  
converted into purple coloured-formazan 
complex by succinate dehydrogenase in 
mitochondria (Doyle and Grifith, 2000). MPE 
exhibit cytotoxic parabolic profile (Figure 1), 
probit analysis yielded MPE IC50 of 45µg/mL.   
The urage of tamoxifen as positive 
control is a estrogen receptor α partial agonis, 
was regarded as first line drug in ER-α over 
expressed breast cancer treatment (Ao et al., 
2011; Fowler et al., 2004). Tamoxifen, was also 
tested against MCF-7 cells by the same 
procedure. Tamoxifen had parabolic cytotoxic 
profile and had IC50 47µM or equal to 12,65.10-
7µg/mL by probit analysis. Tamoxifen had 
strong cytotoxic activity making MCF-7 cells 
broken into debris but MPE (Figure 2). This 
could be explained that tamoxifen is pure 
chemical compound having spesific target on 
the cells. MPE also drived morphological 
changes in MCF-7 cells even it did not make 
the cells broken into debris. MPE contained 
various natural compounds so it did not have 
spesific target compared to THAT 
OFtamoxifen.  
Assay then must be designed in other 
study to confirm molecular mechanism of 
MCF-7 cells. This study used double staining 
method using acridine orange and ethidium 
bromide. Viable cells were green and apoptotic 
cells were red. MPE showed apoptosis 
induction towards MCF-7 cells were dose-
dependent. 
This research used apoptotic cells 17 and 
34µg/mL MPE to investigate apoptotic 
staining.  MCF-7 cells were orange and those 
 
 




Figure 2. Effect of MPE and tamoxifen on MCF-7 morphology after 24h incubation (A) Untreated 
cells (B) 40µg/mL MPE treated cells (C) 10-6µg/mL tamoxifen treated cells. 
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membrane integrity was disturbed (Figure 3). 
MPE has lower cytotoxic and apoptosis 
induction  activity compare to that of 
tamoxifen, it might be due to complexity of 
MPE natural compound.  These novel findings 
underline the benefit of in vitro study to 
elucidate molecular mechanisms of 
chemopreventive agent. 
The molecular mechanism of apoptosis 
induction of MPE on ER-α was confirmed 
using immunocytochemistry method. 
Tamoxifen, a Selective Estrogen Receptor 
Modulators (SERMs), suppress ER-α 
expression. It down regulated ER-α by 
changing conformation of ER-α thus AF-2 
domain is hide so AF-2 dependent  co-activator 
hardly bind to the receptor (Brufsky, 2011). 
Untreated cells showed high expression of ER-
α both in nucleus and cytoplasm. ER-α is 
located   in   nucleus   and  cytoplasm  near  cell  
membrane in the absense and presence of 
estrogen (Cheskis et al., 2007). MCF-7 cells 
treated with 34µg/mL made cells being 
fragmented into debris there fore this study 
MPE with concentratum of 17µg/ml, was used 
is detect ER-α expression. Even MPE had 
strong cytotoxic and apoptosis induction 
activity, it hardly suppressed ER-α expression. 
Is inhibited ER-α signaling pathway and might 
have other protein targets on MCF-7. There 
were 83 genes involved in ER-α signaling 
pathway in positive ER-α cell lines (Chisamore 
et al, 2009). Therefore, other genes involved in 
ER- α signaling pathway must be investigated.  
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Figure 3. Apoptotic cells observation using double staining method under flourencence 
microscope using 400x magnification. (A)Untreated cells,  (B)Cells treated 17µg/mL MPE (Cpoint 
C: MPE concentration should be "cells treated 34ug/mL MPE" (as described on the text) not 'cells 




Figure 4. The observation of ER-α expression using immunocytochemistry method under light 
microscope using 400x magnification. (A)Untreated cells,  (B) Untreated cells without antibody (C) 
MPE 17µg/mL treated cells  (D) tamoxifen  expressed ER-α 
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